ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153325; 2) Community: the network communities that were significantly associated with the response to NSC 153325; 3) Molecule: the relationships between components within communities and NSC 153325; 4) MDR: the compounds that were significantly associated with the NSC 153325.

NSC Compound Enrichment Correlation
NSC 703109 Null 0.00356914129105577 0.22635928
NSC 714379 Null 0.00356914129105577 0.3528197
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.00356914129105577 0.069743072
NSC 372474 Null 0.00385572727186002 0.51710563
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00385572727186002 0.34983348
NSC 695323 Null 0.00385572727186002 0.24432884
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0038671642008129 0.34224174
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0038671642008129 0.37643479
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0038671642008129 0.3575714
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.0038671642008129 0.42934232
Total:84  Current:8    [First] [Prev] [Next] [Last]